Recruiting
Phase 1

Pharmaceutical Intervention

Sponsor:

University of Calgary

Code:

NCT05204836

Conditions

Anterior Cruciate Ligament Tear

Anterior Cruciate Ligament Rupture

Anterior Cruciate Ligament Injuries

Osteo Arthritis Knee

Eligibility Criteria

Sex: All

Age: 25 - 45

Healthy Volunteers: Not accepted

Interventions

Zoledronic Acid Injection

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-22. This information was provided to ClinicalTrials.gov by University of Calgary on 2023-05-18.